146 related articles for article (PubMed ID: 37803793)
21. Urolithin A production drives the effects of pomegranate on the gut microbial metabolism of bile acids and cholesterol in mild dyslipidaemic overweight and obese individuals.
Cortés-Martín A; Iglesias-Aguirre CE; Marín A; Romo-Vaquero M; Vallejo F; Espín JC; Victoria Selma M
Food Funct; 2024 Mar; 15(5):2422-2432. PubMed ID: 38329279
[TBL] [Abstract][Full Text] [Related]
22. Gut microbiota and acylcarnitine metabolites connect the beneficial association between equol and adiposity in adults: a prospective cohort study.
Wu YY; Gou W; Yan Y; Liu CY; Yang Y; Chen D; Xie K; Jiang Z; Fu Y; Zhu HL; Zheng JS; Chen YM
Am J Clin Nutr; 2022 Dec; 116(6):1831-1841. PubMed ID: 36095141
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological Therapy Determines the Gut Microbiota Modulation by a Pomegranate Extract Nutraceutical in Metabolic Syndrome: A Randomized Clinical Trial.
Cortés-Martín A; Iglesias-Aguirre CE; Meoro A; Selma MV; Espín JC
Mol Nutr Food Res; 2021 Mar; 65(6):e2001048. PubMed ID: 33458928
[TBL] [Abstract][Full Text] [Related]
24. Metabolomics profiles of premenopausal women are different based on
Frankenfeld CL; Maskarinec G; Franke AA
Br J Nutr; 2022 Oct; 128(8):1490-1498. PubMed ID: 34763731
[TBL] [Abstract][Full Text] [Related]
25. Identification of urolithin a as a metabolite produced by human colon microflora from ellagic acid and related compounds.
Cerdá B; Periago P; Espín JC; Tomás-Barberán FA
J Agric Food Chem; 2005 Jul; 53(14):5571-6. PubMed ID: 15998116
[TBL] [Abstract][Full Text] [Related]
26. Urolithins, the rescue of "old" metabolites to understand a "new" concept: Metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status.
Tomás-Barberán FA; González-Sarrías A; García-Villalba R; Núñez-Sánchez MA; Selma MV; García-Conesa MT; Espín JC
Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27158799
[TBL] [Abstract][Full Text] [Related]
27. Strawberry processing does not affect the production and urinary excretion of urolithins, ellagic acid metabolites, in humans.
Truchado P; Larrosa M; García-Conesa MT; Cerdá B; Vidal-Guevara ML; Tomás-Barberán FA; Espín JC
J Agric Food Chem; 2012 Jun; 60(23):5749-54. PubMed ID: 22126674
[TBL] [Abstract][Full Text] [Related]
28. Factors driving the inter-individual variability in the metabolism and bioavailability of (poly)phenolic metabolites: A systematic review of human studies.
Favari C; Rinaldi de Alvarenga JF; Sánchez-Martínez L; Tosi N; Mignogna C; Cremonini E; Manach C; Bresciani L; Del Rio D; Mena P
Redox Biol; 2024 May; 71():103095. PubMed ID: 38428187
[TBL] [Abstract][Full Text] [Related]
29. Pomegranate juice alters the microbiota in breast milk and infant stool: a pilot study.
Henning SM; Yang J; Lee RP; Huang J; Thames G; Korn M; Ben-Nissan D; Heber D; Li Z
Food Funct; 2022 May; 13(10):5680-5689. PubMed ID: 35510588
[TBL] [Abstract][Full Text] [Related]
30. Crosstalk between dietary pomegranate and gut microbiota: evidence of health benefits.
Yin Y; Martínez R; Zhang W; Estévez M
Crit Rev Food Sci Nutr; 2023 Jun; ():1-27. PubMed ID: 37335106
[TBL] [Abstract][Full Text] [Related]
31. Microbial Metabolism of the Soy Isoflavones Daidzein and Genistein in Postmenopausal Women: Human Intervention Study Reveals New Metabotypes.
Soukup ST; Engelbert AK; Watzl B; Bub A; Kulling SE
Nutrients; 2023 May; 15(10):. PubMed ID: 37242235
[TBL] [Abstract][Full Text] [Related]
32. Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species.
Selma MV; Beltrán D; García-Villalba R; Espín JC; Tomás-Barberán FA
Food Funct; 2014 Aug; 5(8):1779-84. PubMed ID: 24909569
[TBL] [Abstract][Full Text] [Related]
33. Impact of Dietary Isoflavone Supplementation on the Fecal Microbiota and Its Metabolites in Postmenopausal Women.
Guadamuro L; Azcárate-Peril MA; Tojo R; Mayo B; Delgado S
Int J Environ Res Public Health; 2021 Jul; 18(15):. PubMed ID: 34360231
[TBL] [Abstract][Full Text] [Related]
34. Levels of urinary isoflavones and lignan polyphenols in Japanese women.
Liu W; Tanabe M; Harada KH; Koizumi A
Environ Health Prev Med; 2013 Sep; 18(5):394-400. PubMed ID: 23632985
[TBL] [Abstract][Full Text] [Related]
35. Urolithins: potential biomarkers of gut dysbiosis and disease stage in Parkinson's patients.
Romo-Vaquero M; Fernández-Villalba E; Gil-Martinez AL; Cuenca-Bermejo L; Espín JC; Herrero MT; Selma MV
Food Funct; 2022 Jun; 13(11):6306-6316. PubMed ID: 35611932
[TBL] [Abstract][Full Text] [Related]
36. Interactions of gut microbiota with dietary polyphenols and consequences to human health.
Tomás-Barberán FA; Selma MV; Espín JC
Curr Opin Clin Nutr Metab Care; 2016 Nov; 19(6):471-476. PubMed ID: 27490306
[TBL] [Abstract][Full Text] [Related]
37. Gut microbiota as a driver of the interindividual variability of cardiometabolic effects from tea polyphenols.
Li Q; Van de Wiele T
Crit Rev Food Sci Nutr; 2023; 63(11):1500-1526. PubMed ID: 34515591
[TBL] [Abstract][Full Text] [Related]
38. Potential of Establishing the Corresponding Human Microbial Community in Pseudo Germ-Free Mice through Fecal Microbe Transfer from Three Urolithin Metabotypes.
Xian W; Yang S; Deng Y; Yang Y; Tan Z; Li W; Yang R
J Agric Food Chem; 2022 Aug; 70(30):9388-9398. PubMed ID: 35877603
[TBL] [Abstract][Full Text] [Related]
39. Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.
Frankenfeld CL; Atkinson C; Wähälä K; Lampe JW
Eur J Clin Nutr; 2014 Apr; 68(4):526-30. PubMed ID: 24569543
[TBL] [Abstract][Full Text] [Related]
40.
Iglesias-Aguirre CE; González-Sarrías A; Cortés-Martín A; Romo-Vaquero M; Osuna-Galisteo L; Cerón JJ; Espín JC; Selma MV
Food Funct; 2023 Mar; 14(6):2657-2667. PubMed ID: 36866688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
